Barclays Maintains Equal-Weight on Teladoc Health, Raises Price Target to $9

Benzinga · 3d ago
Barclays analyst Glen Santangelo maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and raises the price target from $7 to $9.